Meet Our Team
Post-doc
Dr. Yong Zhi
Dr. Yong Zhi (also known as Forrest), received his Bachelor degree major as medicinal chemistry in University of Auckland. Thereafter,he started postgraduate training in major of Molecular Medicine in Chonnam National University for Master degree under the supervision of Dr. Rhee Joon haeng, and subsequent to pursuit the doctoral degree of Radiation biotechnology in Korea Atomic Energy Research Institute (KAERI) in 2020.
Dr.Zhi mainly focused on the virulent pathway, epidemiology, and variant types of vaccine development related with these pathogenic bacteria, such as Salmonella Typhimurium and Streptococcus agalactiae. Since joining Tongji University, Dr. Zhi’s current research fields involved with the effects of alterations in tumor microenviroments after novel immunotherapies, including immune checkpoint inhibitors (ICIs), cellular therapies (CAR-T), and oncolytic microorganisms for relapsed and metastatic gynecological cancers.
Pursuing Ph.D.
Yetian Ruan
Yetian Ruan received her bachelor’s degree in clinical medicine from Nanjing Medical University in 2018. Her main research directions include the clinical features and pathogenesis of cervical cancer metastasis, and in vivo pathological diagnosis of microendoscopy for cervical precancerous lesions and early cervical cancer.
Pursuing Ph.D.
Guangxu Cao
Guangxu Cao received his bachelor’s degree from Jinan University in 2020. His research focuses on processing scRNA-seq datasets and exploring the relationship between tumor cells and the microenvironment. Most recently, he is working on exploring the functions and mechanism of tumor infiltrated B cells in cervical cancer.
Pursuing Ph.D.
Yuhan Wang
Yuhan Wang received her bachelor’s degree from Central South University in 2019 and received her master’s degree from Sun Yat-sen University in 2022. Her research focuses on processing tumor-related scRNA-seq datasets and exploring the relationship between tumor cells and the microenvironment. Most recently, she is working on exploring the mechanism of immunotherapy in cervical cancer.
Pursuing Ph.D.
Mengting Xu
Mengting Xu received her master’s degree in Gynecology from Nanjing Medical University in 2023. Her research direction focuses on tumor resistant-related scRNA-seq and tumor immunology.